NTSB Holds Briefing On OH Train Derailment (Link)

https://www.youtube.com/watch?v=XoT3lFMC_yA

byBill Haddad

February 23, 2023

1 minute read

Qualcomm Q2 Earnings Highlights: Revenue Beat, Auto Segment Sees Growth, Q3 Guidance And More

By Chris Katje

May 3, 4:24 PM

Technology and chip company Qualcomm Inc (NASDAQ: QCOM) reported second-quarter financial results after the market close Wednesday. The following are key highlights for investors.

QCOM

Morgan Stanley Maintains Equal-Weight on PagerDuty, Lowers Price Target to $31

By Benzinga Newsdesk

November 21, 10:11 AM

Morgan Stanley analyst Sanjit Singh maintains PagerDuty (NYSE:PD) with a Equal-Weight and lowers the price target from $34 to $31.

Arlo Technologies Sees Q4 EPS $0.06-$0.12 Vs $0.09 Est.; Revenue $129M-$139M Vs $132.68M Est.

By Benzinga Newsdesk

November 9, 5:18 PM

Fourth Quarter 2023 Business Outlook (4)A reconciliation of our business outlook on a GAAP and non-GAAP basis is provided in the following table: Three Months Ended December 31, 2023 Revenue Net Income

ARLO

FDA
News

FDA Accepts Krystal Biotech’s Biologics License Application For Dystrophic Epidermolysis Bullosa

By Benzinga Newsdesk

August 18, 5:02 PM

FDA granted Priority Review designation PDUFA target action date is February 17, 2023 FDA stated that it is not currently planning to hold an advisory committee meeting

KRYS

NTSB Holds Briefing On OH Train Derailment (Link)

Related Posts

Qualcomm Q2 Earnings Highlights: Revenue Beat, Auto Segment Sees Growth, Q3 Guidance And More

Morgan Stanley Maintains Equal-Weight on PagerDuty, Lowers Price Target to $31

Arlo Technologies Sees Q4 EPS $0.06-$0.12 Vs $0.09 Est.; Revenue $129M-$139M Vs $132.68M Est.

FDA Accepts Krystal Biotech’s Biologics License Application For Dystrophic Epidermolysis Bullosa